Childhood obesity: public-health crisis, common sense cure
Free BPC-157 TB-500 blend dosage calculator
Your healthcare provider will calculate a specific starting dose of semaglutide based on your current progress and how your body has reacted to previous treatments
Liraglutide Liraglutide is a daily injectable GLP-1 receptor agonist available in different doses for different indications
Based on the research, IFF has developed consumer personas to depict types of GLP-1 users and their changing preferences
Semaglutide is approved as Ozempic (diabetes, December 2017), Wegovy (obesity, June 2021), and, in oral form, the Ozempic pill (diabetes, 2026, which reformulated and renamed Rybelsus) and the Wegovy pill (weight, December 2025)